Bharat Biotech said all the studies and safety follow-up activities demonstrated “excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc”
Simple ethical design
Bharat Biotech said all the studies and safety follow-up activities demonstrated “excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc”
